83.5 Million Doses of AZ Vaccine Arrive... COVAX Supply Volume

[Asia Economy Reporter Hyungsoo Park] An additional 835,000 doses (417,500 people) of AstraZeneca (AZ) COVID-19 vaccines have arrived. These vaccines were supplied through the international vaccine procurement project 'COVAX Facility.'

The COVID-19 Vaccination Response Promotion Team announced that the COVID-19 vaccines arrived at Incheon Airport around 6:30 PM on the 13th via cargo flight (KE9514).

The total amount of AstraZeneca vaccines the government planned to receive through COVAX in the first half of the year is 2,102,000 doses (1,051,000 people). Including today's shipment, 1,267,000 doses (633,500 people) have been delivered to Korea so far. The remaining 835,000 doses (417,500 people) will be received next month.

AstraZeneca vaccines will be partially used for the second dose vaccinations starting on the 14th. The rest will be used for the first dose vaccinations starting on the 27th of this month, targeting seniors aged 65 to 74, patients with chronic severe respiratory diseases, and teachers and caregivers at kindergartens, daycare centers, and elementary schools (grades 1 and 2).

Vaccines contracted directly with AstraZeneca will also be delivered sequentially. According to the Promotion Team, 597,000 doses (298,500 people) of the vaccines purchased through individual contracts with AstraZeneca will arrive on the 14th. By the first week of June, a total of 7.23 million doses (3.615 million people) will be delivered. The vaccines arriving on the 14th will be shipped from the SK Bioscience factory in Andong, Gyeongbuk.

The government has secured a total of 192 million doses (99 million people) of vaccines so far. Of these, 172 million doses (89 million people) were secured through contracts with individual pharmaceutical companies, and 20 million doses (10 million people) through COVAX.

The quantities by pharmaceutical company are as follows: Pfizer 66 million doses (33 million people), AstraZeneca 20 million doses (10 million people), Janssen (single dose) 6 million doses, Moderna 40 million doses (20 million people), and Novavax 40 million doses (20 million people). Except for Janssen, all vaccines require two doses.

This content was produced with the assistance of AI translation services.